API Pitavastatin Calcium CAS 147526-32-7

Description:

Pitavastatin una cum propria victu ad adiuvandum inferiorem "malum" cholesterolum et adipes (ut LDL, triglycerides) et "bonum" cholesterolum (HDL) in sanguine excitant.

Contactus: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

Whatsapp: LXXXVI CLXXXVI 2503 (LX)XLIII (WeChat & Telegram & Line)

Skype: slhyzy

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio

Pitavastatin una cum propria victu adhibetur adiuvando inferiorem "malum" cholesterolum et adipes (ut LDL, triglycerides) et "bonum" cholesterolum (HDL) in sanguine.

Specificatio:

Product Name	Pitavastatin calcium
Nomen chemicum	calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
Alia Nomen	PitavasttinCalcium;Pitavastatin Calcium/NK-104;(+)-Monocalciunbis{(3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl-3-quinolyl]-3,5-dihydroxy-6-heptenotatum };PitavastatincalciuM(Livalo);Calcium(3R,5S,E)-7-(2-cyclopropyl-Chemicalbook4-(4-fluorophenyl)-quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; ,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoicacid,calciumsalt(2:1);
CAS Number	147526-32-7
Formulae hypotheticae	C25H26CaFNO4
Formula Pondus	463.56
Aspectus	Firmus
Assay	98.0% min
sarcina	20kg/peram/orum, 25kg/peram/orum, vel quod requiris
Repono	Repone continens arcte clausus in loco sicco & frigido.Non exponere solis dirigere.
COA & MSDS	Praesto

Consuetudinem

Pitavastatin Calcium inhibitor competitive est enzyme HMGCR (HMG-CoA reductase) in reductione synthesis cholesteroli LDL.Studia alterna ostendunt pitavastatin productionem oxygenii posse supprimere in cellulis endothelialibus, inhibitione oxidasi NADPH.Praeterea pitavastatin expressionem eNOS mRNA minuit dum responsio dependens NO augens ab acetylcholino ac calcii ionophore excitata, A23187.Praeterea pitavastatin inhibet regulam conductionis calcii-canales potassium effectae per gradus cholesteroli in cellulis demisso.